Roles for advance practice registered nurses are expanding in cancer centers.
The occurrence rate of BIA-ALCL following breast augmentation with textured implants is variable, with the reported lifetime risk ranging from 1 in 355 to 1 in 86,029 patients.
Nurse practitioners play an essential role in the chemotherapy plan for patients with cancer.
Investigators examined the effects of bariatric surgery on cancer risk in patients with NAFLD and severe obesity.
The myeloid index score captures the prognostic value of blood myeloid cells and may be used in the management of patients with melanoma.
A team of investigators conducted a randomized controlled trial to assess outcomes following salvage endoscopic surgery vs radiation therapy in patients with resectable, locally recurrent nasopharyngeal cancer.
Use of chemotherapy among patients aged 80 years and older with metastatic non-small cell lung cancer (NSCLC) was linked to longer overall survival.
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care.
A structured surveillance program for high-risk melanoma patients can be scaled and successfully replicated even in a primary care skin cancer clinic.
Results of an assessment of tissue composition changes experienced by breast cancer survivors without lymphedema are presented.
High area-level socioeconomic deprivation is associated with worse survival for patients with cancer enrolled in clinical trials.
Vitamin D supplementation is associated with a 13% decrease in progression to diabetes in patients with prediabetes.
A team of international researchers sought to confirm a “dual pathway hypothesis” for the development of melanoma.
Researchers sought to determine whether idecabtagene vicleucel, a CAR-T cell therapy, would be a viable treatment option in heavily pretreated patients with relapsed or refractory multiple myeloma.
A team of researchers sought to evaluate familial risks of developing breast cancer among women with a family history of cancers other than breast cancer.
To prove clinical benefit, the FDA requires manufacturers to conduct confirmatory trials, also known as a phase 4 studies.
An analysis of data from the VA healthcare system revealed a gap in recommended assessments of cardiovascular risk factors among men with prostate cancer.
There is significant divergence between patients’, nurses’, and surgeons’ perceptions of breast cancer treatment knowledge.
Cervical cancer screening rates remained below normal levels even after the stay-at-home order was lifted.
February is American Heart Month, and patients who have been diagnosed with cancer are part of a group that is uniquely vulnerable to cardiovascular disease. What risk factors should these patients know about for fatal heart disease?